Hartley must have cleared substantially if not fully, we are about to get some further good news soon. PLS also had a sell down before they started to climb. Hopefully we are going along the same path. There is some nibbling at this level before others joining in.
On the fundamentals front, now that the PFS is out, they can speak in confidence to off takers what we have for the market. JM must also be in a position to talk to funders for our project. It must also sound logical and reasonable for directors to convert part of their performing rights into shares to show their confidence. Our ammunition are ready and the shots are about to be fired. Is everyone on board?
- Forums
- ASX - By Stock
- FFX
- Ann: 2018 PFS Roadshow Presentation
Ann: 2018 PFS Roadshow Presentation, page-113
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online